#31372
Janet Wilpstra
Participant

Diabetes Education

Google answer:
Data from DURATION-1 demonstrated that continuous HbA1c reductions and weight loss were observed for the patients continuing on the treatment, with no unexpected adverse events. Taken together, these data support GLP-1RAs as a long-term noninsulin treatment option after the failure of oral therapy.

We are responsible to monitor for changes in client status…regular DEP visits and bloodwork

Scroll to Top

The
Essentials

Welcome,

Programs

Diabetes Canada

The Essentials